AAAAAA
Results:
1-13
|
Results: 13
Authors:
Chassain, C
Eschalier, A
Durif, F
Citation: C. Chassain et al., Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP, J NEUROSC M, 111(1), 2001, pp. 9-16
Authors:
Bonny, JM
Durif, F
Bazin, JE
Touraille, E
Yelnik, J
Renou, JP
Citation: Jm. Bonny et al., Contrast optimization of Macaca mulatta basal ganglia in magnetic resonance images at 4.7 Tesla, J NEUROSC M, 107(1-2), 2001, pp. 25-30
Authors:
Vidailhet, M
Tassin, J
Durif, F
Nivelon-Chevallier, A
Agid, Y
Brice, A
Durr, A
Citation: M. Vidailhet et al., A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q, NEUROLOGY, 56(9), 2001, pp. 1213-1216
Authors:
Durif, F
Devaux, I
Pere, JJ
Delumeau, JC
Bourdeix, I
Citation: F. Durif et al., Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in dailymedical practice: An open, multicenter study, EUR NEUROL, 45(2), 2001, pp. 111-118
Authors:
Durr, A
Tassin, J
Vidailhet, M
Durif, F
Jedynak, P
Agid, Y
Brice, A
Citation: A. Durr et al., D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus, ANN NEUROL, 48(1), 2000, pp. 127-128
Authors:
Tassin, J
Durr, A
Bonnet, AM
Gil, R
Vidailhet, M
Lucking, CB
Goas, JY
Durif, F
Abada, M
Echenne, B
Motte, J
Lagueny, A
Lacomblez, L
Jedynak, P
Bartholome, B
Agid, Y
Brice, A
Citation: J. Tassin et al., Levodopa-responsive dystonia - GTP cyclohydrolase I or parkin mutations?, BRAIN, 123, 2000, pp. 1112-1121
Authors:
Durif, F
Citation: F. Durif, Treating and preventing levodopa-induced dyskinesias - Current and future strategies, DRUG AGING, 14(5), 1999, pp. 337-345
Authors:
Durif, F
Vidailhet, M
Debilly, B
Agid, Y
Citation: F. Durif et al., Worsening of levodopa-induced dyskinesias by motor and mental tasks, MOVEMENT D, 14(2), 1999, pp. 242-245
Authors:
Agid, Y
Destee, A
Durif, F
Montastruc, JL
Pedarriosse, AM
Deptula, D
Hoffman-La Roche, F
Pollak, P
Bonnet, AM
Allain, H
le Cavorzin, P
Barroche, G
Blin, O
Cesaro, P
Chazot, G
Broussolle, E
Leduc, V
Debilly, B
Feve, JR
Geraud, G
Fabre, N
Gu, C
Gil, R
Henry, P
Tison, F
Ansquer, O
Brefel, C
Payen, I
Said, G
Plante, V
Touchon, J
Cesari, JB
Camu, W
Bennys, K
Viallet, F
Warter, JM
Tranchant, C
Ziegler, M
Citation: Y. Agid et al., Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients, MOVEMENT D, 14(1), 1999, pp. 38-44
Authors:
Vidailhet, M
Bonnet, AM
Marconi, R
Durif, F
Agid, Y
Citation: M. Vidailhet et al., The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease, MOVEMENT D, 14, 1999, pp. 13-18
Authors:
Pollak, P
Destee, A
Lille, CHU
Tison, F
Pere, JJ
Malmaison, R
Bordeix, I
Agid, Y
Allain, H
Borg, M
Broussolle, E
Durif, F
Geny, C
Prunier-Levilon, C
Bretonneau, CHU
Rascol, O
Sangla, S
Verin, M
Viallet, F
Tranchant, C
Citation: P. Pollak et al., Clozapine in drug-induced psychosis in Parkinson's disease, LANCET, 353(9169), 1999, pp. 2041-2042
Authors:
Durif, F
Lemaire, JJ
Debilly, B
Dordain, G
Citation: F. Durif et al., Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease, J NE NE PSY, 67(3), 1999, pp. 315-322
Authors:
Lemaire, JJ
Durif, F
Boire, JY
Debilly, B
Irthum, B
Chazal, J
Citation: Jj. Lemaire et al., Direct stereotactic MRI location in the globus pallidus for chronic stimulation in Parkinson's disease, ACT NEUROCH, 141(7), 1999, pp. 759-766
Risultati:
1-13
|